ENDOZYME® II Automated Endotoxin Detection Assay with Andrew+
This advanced method offers an end-to-end solution developed around an advanced application, a specialized kit, or an analytical system. It delivers complete functional, ready-to-use protocols that are qualitatively and quantitatively assessed for consistency, executability, and repeatability, usually without needing to make any changes. It operates per batch size and is scalable to accommodate changing requirements.
Published by
bioMérieux
Version 1, 27 Sep 2026 at 9:23 AM
Endotoxin testing is a mandatory release test for injectable drugs and medical devices. ENDOZYME® II is a rFC based endotoxin test in a 96-Well microplate format.
Get in touch with an expert about running this protocol on Andrew+.
Please note that this is a “Click & Execute Method”
This advanced method offers an end-to-end solution developed around an advanced application, a specialized kit, or an analytical system. It delivers complete functional, ready-to-use protocols that are qualitatively and quantitatively assessed for consistency, executability, and repeatability, usually without needing to make any changes. It operates per batch size and is scalable to accommodate changing requirements.
Protocols
1
ENDOZYME II
Testing 20 samples with no dilution (or previously diluted) with a 4 points curve (5 to 0,005 EU/ml)
Contact info
Published by
bioMérieux
bioMérieux is a global leader in in vitro diagnostics. Since 1963 it builds diagnostic solutions that help healthcare and industry make reliable decisions to protect patients and ensure safety. Its purpose is clear: help make the world a healthier place.
This is an open access protocol distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. 